Literature DB >> 19237906

Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation.

Alexander O Spiel1, Martin Frossard, Florian B Mayr, Andreas Kliegel, Andreas Janata, Thomas Uray, Cosima Wandaller, Fritz Sterz, Bernd Jilma.   

Abstract

OBJECTIVE: Markers of platelet activation are increased in patients undergoing cardiopulmonary resuscitation. Hyperfunctional platelets may contribute to impairment of microcirculatory function and overall poor outcome despite restoration of spontaneous circulation (ROSC). Patients with myocardial infarction have hyperfunctional platelets, which predict the degree of myocardial necrosis. Thus, we hypothesized that platelets may be even more activated in patients whose myocardial infarction leads to cardiac arrest and compared them with patients whose cardiac arrest was due to a noncardiac origin.
DESIGN: Prospective observational study.
SETTING: Emergency department of a tertiary care hospital. PATIENTS: One hundred four patients with witnessed cardiac arrest who achieved ROSC.
INTERVENTIONS: Blood sampling.
MEASUREMENTS AND MAIN RESULTS: We assessed collagen adenosine diphosphate closure time with the platelet function analyzer-100, and measured plasma levels of von Willebrand factor: ristocetin cofactor activity levels by turbidometry. Independent physicians diagnosed the origin of cardiac arrest. The majority of cardiac arrests were caused by myocardial ischemia. Invariably, collagen adenosine diphosphate closure time values (55 seconds; 95% confidence interval: 52-58 seconds) were much shorter in these patients compared with patients with other causes of cardiac arrest (110 seconds; 95% confidence interval: 84-135 seconds, p < 0.001). von Willebrand factor: ristocetin cofactor activity plasma levels were more than three-fold above normal values in both groups.
CONCLUSIONS: Patients with myocardial ischemia-triggered cardiac arrest had the highest degree of platelet hyperfunction under high shear rates, which was not solely due to increased von Willebrand factor. Future trials are necessary to clarify whether rapid, more aggressive antiplatelet therapy improves outcome after cardiac arrest.

Entities:  

Mesh:

Year:  2009        PMID: 19237906     DOI: 10.1097/CCM.0b013e3181962cb9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Platelet aggregation in severe sepsis.

Authors:  Gábor Woth; Adrienn Varga; Subhamay Ghosh; Miklós Krupp; Tamás Kiss; Lajos Bogár; Diana Mühl
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  Coagulopathy during cardiac arrest and resuscitation in a swine model of electrically induced ventricular fibrillation.

Authors:  Nathan J White; Benjamin Sieu-Hon Leong; Jessica Brueckner; Erika J Martin; Donald F Brophy; Mary A Peberdy; Joseph Ornato; Kevin R Ward
Journal:  Resuscitation       Date:  2011-04-08       Impact factor: 5.262

3.  Platelet indices and outcome after cardiac arrest.

Authors:  Antonella Cotoia; Federico Franchi; Chiara De Fazio; Jean-Louis Vincent; Jacques Creteur; Fabio Silvio Taccone
Journal:  BMC Emerg Med       Date:  2018-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.